Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Adcentrx and AvantGen Enter a New Partnership with a Three-year, Multi-target Collaboration to Discover Antibodies for Novel Antibody-drug Conjugates
Adcentrx Therapeutics (“Adcentrx”), a biotechnology company focused on accelerating breakthroughs in antibody drug conjugate (“ADC”) […]
Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Pfizer Inc. (NYSE: PFE), today announced positive top-line results […]
MayaMD & LG Electronics Offer New AI Healthcare at Home Program Via Smart TV
MayaMD, one of LG NOVA’s Proto Challenge first winners, will offer its AI health assistant […]
Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Clinical Safety Prediction
Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has signed […]
Healx and Ovid Therapeutics Enter Strategic Partnership
Ovid Therapeutics (NASDAQ:OVID) (“Ovid”), a biopharmaceutical company committed to developing medicines that transform the lives of […]
Oncode Institute and ArgoBio Launch Laigo Bio, a Targeted Protein Degradation Biotech with Programs in Oncology and Neurological Disorders
ArgoBio and Oncode Institute have teamed up with Oncode Investigator Madelon Maurice, researcher and group leader at UMC Utrecht, to launch […]
Pfizer and Alex Therapeutics Announce a Strategic Commercial Partnership to Provide Evidence-based Digital Therapeutics to Patients, Starting in Germany
The Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics and world leading pharmaceutical company Pfizer have joined […]
Antiverse Collaborates with a Top 20 Pharma Company to Identify Antibody Drug Candidates Using AI Augmented Drug Discovery Platform
Antiverse, a biotechnology company developing a computational antibody drug discovery platform, today announced a partnership […]
Tollys Accelerates Development of TLR3 Agonist Candidates for Intravenous Administration in Immuno-oncology
Tollys, a biopharmaceutical company developing the first anti-cancer immunotherapy based on a synthetic Toll-Like Receptor […]
IAVI and Moderna Launch Trial of HIV Vaccine Antigens Delivered Through mRNA Technology
IAVI, the nonprofit scientific research organization, and biotechnology company Moderna announced today that first doses […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more